Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice (IRIS-DES)

Seung-Jung Park

Status: Enrolling

Conditions: Coronary Artery Disease; Percutaneous Transluminal Coronary Angioplasty

Study type: Observational

Funder types: Other

Identifiers

NCT01186133

2010-035

Details and patient eligibility

About

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Full description

Consecutive patients receiving New DES without a mixture of other DES

Enrollment: 50,000 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• coronary disease amenable to percutaneous coronary intervention (PCI)
• no clinical and lesion limitations

Exclusion criteria

• patients with a mixture of several DES
• terminal illness with life expectancy less than 1 year
• patients with cardiogenic shock

Trial design

50,000 participants in 27 patient groups

DESSIAN

Description:

consecutive patients receiving CYPHER stent

K-XIENCE

Description:

consecutive patients receiving Xience stent

GENOUS

Description:

consecutive patients receiving GENOUS stent

ELEMENT

Description:

consecutive patients receiving PROMUS-ELEMENT stent

PRIME

Description:

consecutive patients receiving XIENCE-PRIME stent

NOBORI

Description:

consecutive patients receiving NOBORI stent

INTEGRITY

Description:

consecutive patients receiving RESOLUTE-INTEGRITY stent

XPEDITION

Description:

consecutive patients receiving XIENCE-XPEDITION stent

BIOMATRIX

Description:

consecutive patients receiving BIOMATRIX stent

CILOTAX

Description:

consecutive patients receiving CILOTAX stent

DEB

Description:

consecutive patients receiving Drug eluting balloon

DESYNE

Description:

consecutive patients receiving DESYNE stent

PREMIER

Description:

consecutive patients receiving PROMUS-PREMIER stent

ORSIRO

Description:

consecutive patients receiving ORSIRO stent

ONYX

Description:

consecutive patients receiving ONYX stent

BVS

Description:

consecutive patients receiving Bioresorbable Vascular Scaffold

BVS AMI

Description:

consecutive acute myocardial infarction patients receiving Bioresorbable Vascular Scaffold

Ultimaster

Description:

consecutive patients receiving Ultimaster stent

Synergy

Description:

consecutive patients receiving Synergy stent

Biofreedom

Description:

consecutive patients receiving Biofreedom stent

Firehawk

Description:

consecutive patients receiving Firehawk stent

DESyne X2

Description:

consecutive patients receiving DESyne X2 stent

Sierra

Description:

consecutive patients receiving Sierra stent

Tansei

Description:

consecutive patients receiving Tansei stent

Synergy XD and Synergy Megatron™

Description:

consecutive patients receiving Synergy XD or Synergy Megatron™ stent

Xience-Skypoint

Description:

consecutive patients receiving Xience-Skypoint stent

Coroflex ISAR NEO

Description:

consecutive patients receiving Coroflex ISAR NEO stent